Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01E" (283)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Dasatinib (L01EA02) 42 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
SIP
IP
CI
Sprycel 20 mg
60 Tablet(s)
968.80
1040.20
20 %
Coated tablets: Dasatinibum 20 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
SIP
IP
CI
Sprycel 50 mg
60 Tablet(s)
2145.50
2283.75
20 %
Coated tablets: Dasatinibum 50 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
SIP
IP
CI
Sprycel 70 mg
60 Tablet(s)
2145.50
2283.75
20 %
Coated tablets: Dasatinibum 70 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
SIP
IP
CI
Sprycel 100 mg
30 Tablet(s)
2205.04
2346.65
20 %
Coated tablets: Dasatinibum 100 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
IP
CI
Dasatinib Accord 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Accord 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Accord 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Accord 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Sandoz 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Sandoz 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Sandoz 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Sandoz 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Spirig HC 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Spirig HC 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Spirig HC 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Spirig HC 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Zentiva 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Helvepharm AG
●
A / SL / SG
FB
G
L
IP
CI
Dasatinib Zentiva 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Zentiva 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib Zentiva 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib-Teva 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib-Teva 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib-Teva 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
CI
Dasatinib-Teva 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Teva Pharma AG
A / SL / SG
FB
G
IP
CI
Dasatinib Accord 80 mg
30
k.A.
Coated tablets: Dasatinibum 80 mg
Accord Healthcare AG
A
FB
G
IP
CI
Dasatinib Accord 140 mg
30
k.A.
Coated tablets: Dasatinibum 140 mg
Accord Healthcare AG
A
FB
G
IP
CI
Dasatinib Sandoz 80 mg
30
k.A.
Coated tablets: Dasatinibum 80 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Dasatinib Sandoz 140 mg
30
k.A.
Coated tablets: Dasatinibum 140 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Dasatinib-Teva 20 mg
60
k.A.
Coated tablets: Dasatinibum 20 mg
Teva Pharma AG
A
FB
G
IP
CI
Dasatinib-Teva 50 mg
60
k.A.
Coated tablets: Dasatinibum 50 mg
Teva Pharma AG
A
FB
G
IP
CI
Dasatinib-Teva 70 mg
60
k.A.
Coated tablets: Dasatinibum 70 mg
Teva Pharma AG
A
FB
G
IP
CI
Dasatinib-Teva 80 mg
30
k.A.
Coated tablets: Dasatinibum 80 mg
Teva Pharma AG
A
FB
G
IP
CI
Dasatinib-Teva 80 mg
30
k.A.
Coated tablets: Dasatinibum 80 mg
Teva Pharma AG
A
FB
G
IP
CI
Dasatinib-Teva 100 mg
30
k.A.
Coated tablets: Dasatinibum 100 mg
Teva Pharma AG
A
FB
G
SIP
IP
CI
Sprycel 20 mg
60 Tablet(s)
k.A.
Coated tablets: Dasatinibum 20 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 50 mg
60 Tablet(s)
k.A.
Coated tablets: Dasatinibum 50 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 70 mg
60 Tablet(s)
k.A.
Coated tablets: Dasatinibum 70 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 80 mg
30 Tablet(s)
k.A.
Coated tablets: Dasatinibum 80 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 80 mg
30 Tablet(s)
k.A.
Coated tablets: Dasatinibum 80 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 100 mg
30 Tablet(s)
k.A.
Coated tablets: Dasatinibum 100 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 140 mg
30 Tablet(s)
k.A.
Coated tablets: Dasatinibum 140 mg
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Sprycel 140 mg
30 Tablet(s)
k.A.
Coated tablets: Dasatinibum 140 mg
Bristol-Myers Squibb SA
A
FB
G
Bosutinib (L01EA04) 12 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Bosulif 100 mg
28 Tablet(s)
558.25
609.80
20 %
Coated tablets: Bosutinibum 100 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Bosulif 400 mg
28
2233.00
2389.95
20 %
Coated tablets: Bosutinibum 400 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Bosulif 500 mg
28 Tablet(s)
2631.38
2813.40
20 %
Coated tablets: Bosutinibum 500 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Bosutinib Sandoz 100 mg
28
334.95
380.70
10 %
Coated tablets: Bosutinibum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Bosutinib Sandoz 400 mg
28
1339.80
1473.55
10 %
Coated tablets: Bosutinibum 400 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Bosutinib Sandoz 500 mg
28
1578.83
1733.50
10 %
Coated tablets: Bosutinibum 500 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Bosutinib Spirig HC 100 mg
28
334.95
380.70
10 %
Coated tablets: Bosutinibum 100 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Bosutinib Spirig HC 400 mg
28
1339.80
1473.55
10 %
Coated tablets: Bosutinibum 400 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Bosutinib Spirig HC 500 mg
28
1578.82
1733.50
10 %
Coated tablets: Bosutinibum 500 mg
Spirig HealthCare AG
A / SL / SG
FB
G
Bosutinib-Teva 100 mg
28
k.A.
Coated tablets: Bosutinibum 100 mg
Teva Pharma AG
A
FB
G
Bosutinib-Teva 400 mg
28
k.A.
Coated tablets: Bosutinibum 400 mg
Teva Pharma AG
A
FB
G
Bosutinib-Teva 500 mg
28
k.A.
Coated tablets: Bosutinibum 500 mg
Teva Pharma AG
A
FB
G
Asciminib (L01EA06) 3 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Scemblix 20 mg
60
1844.31
2022.20
10 %
Coated tablets: Asciminibum 20 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Scemblix 40 mg
60
3688.62
4028.00
10 %
Coated tablets: Asciminibum 40 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
IP
CI
Scemblix 100 mg
120
k.A.
Coated tablets: Asciminibum 100 mg
Novartis Pharma
Schweiz AG
A
FB
G
Afatinib (L01EB03) 4 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Giotrif 20 mg
28 Tablet(s)
2116.41
2318.15
10 %
Coated tablets: Afatinibum 20 mg
Boehringer Ingelheim
(Schweiz) GmbH
A / SL
FB
G
L
IP
CI
Giotrif 30 mg
28 Tablet(s)
2116.41
2318.15
10 %
Coated tablets: Afatinibum 30 mg
Boehringer Ingelheim
(Schweiz) GmbH
A / SL
FB
G
L
IP
CI
Giotrif 40 mg
28 Tablet(s)
2116.41
2318.15
10 %
Coated tablets: Afatinibum 40 mg
Boehringer Ingelheim
(Schweiz) GmbH
A / SL
FB
G
IP
CI
Giotrif 50 mg
28
k.A.
Coated tablets: Afatinibum 50 mg
Boehringer Ingelheim
(Schweiz) GmbH
A
FB
G
Dabrafenib (L01EC02) 5 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Tafinlar 50 mg
28 Capsule(s)
820.18
908.40
10 %
Capsules: Dabrafenibum 50 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Tafinlar 50 mg
120 Capsule(s)
3515.06
3839.25
10 %
Capsules: Dabrafenibum 50 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Tafinlar 75 mg
28 Capsule(s)
1230.27
1354.40
10 %
Capsules: Dabrafenibum 75 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Tafinlar 75 mg
120 Capsule(s)
5272.59
5717.50
10 %
Capsules: Dabrafenibum 75 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
IP
CI
Tafinlar 10 mg
210
k.A.
Tablette zur Herstellung einer Suspension zum Einnehmen: Dabrafenibum 10 mg
Novartis Pharma
Schweiz AG
A
FB
G
Crizotinib (L01ED01) 5 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
PP
Xalkori 200 mg
60 Capsule(s)
3716.38
4058.20
10 %
Capsules: Crizotinibum 200 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Xalkori 250 mg
60 Capsule(s)
4645.48
5068.65
10 %
Capsules: Crizotinibum 250 mg
Pfizer AG
A / SL
FB
G
IP
CI
Xalkori 20 mg
60
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 20 mg
Pfizer AG
A
FB
G
IP
Xalkori 50 mg
60
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 50 mg
Pfizer AG
A
FB
G
IP
Xalkori 150 mg
60
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 150 mg
Pfizer AG
A
FB
G
Ceritinib (L01ED02) 1 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Zykadia
84
4003.77
4370.75
10 %
Coated tablets: Ceritinibum 150 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
Alectinib (L01ED03) 1 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
PP
Alecensa 150 mg
224
4344.43
4741.25
10 %
Capsules: Alectinibum 150 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Brigatinib (L01ED04) 7 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Alunbrig 30 mg
28
722.39
802.05
10 %
Coated tablets: Brigatinibum 30 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Alunbrig 90 mg
7
541.79
605.65
10 %
Coated tablets: Brigatinibum 90 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Alunbrig 90 mg
28
2167.16
2373.35
10 %
Coated tablets: Brigatinibum 90 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Alunbrig 180 mg
28
4334.31
4730.25
10 %
Coated tablets: Brigatinibum 180 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Alunbrig 180 mg
7 + 21
4334.31
4730.25
10 %
Coated tablets: Brigatinibum 180 mg
Takeda Pharma AG
A / SL
FB
G
IP
CI
Alunbrig 30 mg
56
k.A.
Coated tablets: Brigatinibum 30 mg
Takeda Pharma AG
A
FB
G
IP
CI
Alunbrig 30 mg
112
k.A.
Coated tablets: Brigatinibum 30 mg
Takeda Pharma AG
A
FB
G
Cobimetinib (L01EE02) 1 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
PP
Cotellic 20mg
63 Tablet(s)
4891.99
5327.00
10 %
Coated tablets: Cobimetinibum 20 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Binimetinib (L01EE03) 4 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Mektovi 15 mg
84
2147.80
2352.30
10 %
Coated tablets: Binimetinibum 15 mg
Pierre Fabre Pharma SA
A / SL
FB
G
L
IP
CI
Mektovi 15 mg
168
4295.60
4688.15
10 %
Coated tablets: Binimetinibum 15 mg
Pierre Fabre Pharma SA
A / SL
FB
G
L
IP
CI
Mektovi 45 mg
28
2147.80
2352.30
10 %
Coated tablets: Binimetinibum 45 mg
Pierre Fabre Pharma SA
A / SL
FB
G
L
IP
CI
Mektovi 45 mg
56
4295.60
4688.15
10 %
Coated tablets: Binimetinibum 45 mg
Pierre Fabre Pharma SA
A / SL
FB
G
Abemaciclib (L01EF03) 8 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Verzenios 50 mg
28
988.00
1090.95
10 %
Coated tablets: Abemaciclibum 50 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 50 mg
56
1976.00
2165.45
10 %
Coated tablets: Abemaciclibum 50 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 100 mg
28
988.00
1090.95
10 %
Coated tablets: Abemaciclibum 100 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 100 mg
56
1976.00
2165.45
10 %
Coated tablets: Abemaciclibum 100 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 150 mg
28
988.00
1090.95
10 %
Coated tablets: Abemaciclibum 150 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 150 mg
56
1976.00
2165.45
10 %
Coated tablets: Abemaciclibum 150 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
IP
CI
Verzenios 200 mg
28
1423.07
1623.85
k.A.
Coated tablets: Abemaciclibum 200 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
CI
Verzenios 200 mg
56
2841.39
3158.40
k.A.
Coated tablets: Abemaciclibum 200 mg
Eli Lilly (Suisse) SA
A
FB
G
Axitinib (L01EK01) 18 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Inlyta 1 mg
28 Tablet(s)
269.87
304.65
10 %
Coated tablets: Axitinibum 1 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Inlyta 1 mg
56 Tablet(s)
539.74
592.85
10 %
Coated tablets: Axitinibum 1 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Inlyta 3 mg
28 Tablet(s)
809.61
881.05
10 %
Coated tablets: Axitinibum 3 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Inlyta 5 mg
28 Tablet(s)
1349.35
1457.50
10 %
Coated tablets: Axitinibum 5 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Inlyta 5 mg
56 Tablet(s)
2698.70
2898.55
10 %
Coated tablets: Axitinibum 5 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Inlyta 7 mg
28 Tablet(s)
1889.09
2033.90
10 %
Coated tablets: Axitinibum 7 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
CI
Axitinib Sandoz 1 mg
28
184.00
216.55
10 %
Coated tablets: Axitinibum 1 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Sandoz 1 mg
56
368.00
416.65
10 %
Coated tablets: Axitinibum 1 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Sandoz 3 mg
28
552.00
616.75
10 %
Coated tablets: Axitinibum 3 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Sandoz 5 mg
28
920.00
1016.95
10 %
Coated tablets: Axitinibum 5 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Sandoz 5 mg
56
1840.00
2017.55
10 %
Coated tablets: Axitinibum 5 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Sandoz 7 mg
28
1288.00
1417.20
10 %
Coated tablets: Axitinibum 7 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Spirig HC 1 mg
28
184.00
216.55
10 %
Coated tablets: Axitinibum 1 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Spirig HC 1 mg
56
368.00
416.65
10 %
Coated tablets: Axitinibum 1 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Spirig HC 3 mg
28
552.00
616.75
10 %
Coated tablets: Axitinibum 3 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Spirig HC 5 mg
28
920.00
1016.95
10 %
Coated tablets: Axitinibum 5 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Spirig HC 5 mg
56
1840.00
2017.55
10 %
Coated tablets: Axitinibum 5 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Axitinib Spirig HC 7 mg
28
1288.00
1417.20
10 %
Coated tablets: Axitinibum 7 mg
Spirig HealthCare AG
A / SL / SG
FB
G
Bruton'S Tyrosine Kinase (Btk) Inhibitors (L01EL) 6 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
IP
CI
Jaypirca 50 mg
28
k.A.
Coated tablets: Pirtobrutinibum 50 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
CI
Jaypirca 100 mg
56
k.A.
Coated tablets: Pirtobrutinibum 100 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
CI
Jaypirca 50 mg
30
k.A.
Coated tablets: Pirtobrutinibum 50 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
CI
Jaypirca 100 mg
28
k.A.
Coated tablets: Pirtobrutinibum 100 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
CI
Jaypirca 100 mg
30
k.A.
Coated tablets: Pirtobrutinibum 100 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
CI
Jaypirca 100 mg
60
k.A.
Coated tablets: Pirtobrutinibum 100 mg
Eli Lilly (Suisse) SA
A
FB
G
Acalabrutinib (L01EL02) 2 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Calquence 100 mg
60
4348.28
4745.45
10 %
Coated tablets: Acalabrutinibum 100 mg
AstraZeneca AG
A / SL
FB
G
IP
CI
Calquence 100 mg
60
4526.77
4939.55
k.A.
Capsules: Acalabrutinibum 100 mg
AstraZeneca AG
A
FB
G
Alpelisib (L01EM03) 6 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Piqray 150 mg
28
1483.58
1629.90
10 %
Coated tablets: Alpelisibum 150 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Piqray 150 mg
56
2982.21
3259.75
10 %
Coated tablets: Alpelisibum 150 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Piqray 200 mg
28
2982.21
3259.75
10 %
Coated tablets: Alpelisibum 200 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Piqray 200 mg + 50 mg
14
1483.58
1629.90
10 %
Coated tablets: Alpelisibum 200 mg
Coated tablets: Alpelisibum 50 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Piqray 200 mg + 50 mg
28
2982.21
3259.75
10 %
Coated tablets: Alpelisibum 200 mg
Coated tablets: Alpelisibum 50 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
IP
CI
Piqray 200 mg
14
k.A.
Coated tablets: Alpelisibum 200 mg
Novartis Pharma
Schweiz AG
A
FB
G
Cabozantinib (L01EX07) 3 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
PP
Cabometyx 60 mg
30
4670.20
5095.55
10 %
Coated tablets: 2 Active Agents
Aspen Pharma Schweiz
GmbH
A / SL
FB
G
L
IP
CI
PP
Cabometyx 20 mg
30
4670.20
5095.55
10 %
Coated tablets: Cabozantinibum 20 mg
Aspen Pharma Schweiz
GmbH
A / SL
FB
G
L
IP
CI
PP
Cabometyx 40 mg
30
4670.20
5095.55
10 %
Coated tablets: Cabozantinibum 40 mg
Aspen Pharma Schweiz
GmbH
A / SL
FB
G
Capmatinib (L01EX17) 2 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Tabrecta 150 mg
120
5503.34
5954.25
10 %
Coated tablets: Capmatinibum 150 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Tabrecta 200 mg
120
5503.34
5954.25
10 %
Coated tablets: Capmatinibum 200 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
Avapritinib (L01EX18) 5 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
IP
CI
Ayvakyt 25 mg
30
k.A.
Coated tablets: Avapritinibum 25 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 50 mg
30
k.A.
Coated tablets: Avapritinibum 50 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 100 mg
30
k.A.
Coated tablets: Avapritinibum 100 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 200 mg
30
k.A.
Coated tablets: Avapritinibum 200 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 300 mg
30
k.A.
Coated tablets: Avapritinibum 300 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
